Topic
AI Research
Artificial Intelligence continues to be a primary catalyst for global equity performance, with AI-related indices significantly outperforming the S&P 500 and driving a widening valuation gap between US and global markets. This growth has led to unprecedented concentration in hedge fund portfolios, where crowded Tech longs and record-high gross leverage present significant reversal risks, drawing historical parallels to the mid-1990s Netscape cycle. Beyond public equities, AI adoption is fundamentally reshaping private markets, directing capital toward strategic infrastructure like data centers and defense technology as part of a 'new world order.' In the context of a fragmented global economy, emerging markets are gaining traction as essential hubs for AI manufacturing, supporting attractive outlooks for EM equities through 2026. Additionally, institutional investors are increasingly integrating machine learning quantitative screens into their proprietary methodologies to identify high-yield opportunities in structured products. Collectively, these insights underscore AI's role not just as a thematic tailwind, but as a critical component in both investment infrastructure and geopolitical strategy.
4190 reports available
All reports
Page 166 of 175
China AIDC and Power Corporate Day Takeaways
Goldman Sachs · May 11, 2026
BinDawood Holding 1Q26 Earnings First Take
Goldman Sachs · May 11, 2026
Cenomi Centers 1Q26 Earnings Call Takeaways
Goldman Sachs · May 11, 2026
Key Takeaways From 1Q26 Conference Call - Caixa Seguridade
Goldman Sachs · May 11, 2026
Looking for R&D Levers
Goldman Sachs · May 11, 2026
European Contextual Diary
UBS · May 11, 2026
Auto1 Group: April 2026 High Frequency Data Update
Goldman Sachs · May 11, 2026
Sentiment Buoyed by Hopes of a US-Iran Deal
Crédit Agricole CIB · May 11, 2026
Two Things to Watch in the Coming Week
UBS · May 11, 2026
US Market Intelligence Morning Briefing
J.P. Morgan · May 11, 2026
Good Morning Mail
Goldman Sachs · May 11, 2026
Americas Small Cap Research Summary
Barclays · May 11, 2026
Evaluating Execution Risk for Avexitide Phase 3 Readout in Post-Bariatric Hypoglycemia
Goldman Sachs · May 11, 2026
Australian Morning Focus
ANZ · May 11, 2026
India Insight: Between Headwinds and Constraints
ANZ · May 11, 2026
Asia FX Talk: USD Capped Despite Stronger-Than-Consensus NFP
MUFG · May 11, 2026
Global Weekly Kickstart
Goldman Sachs · May 11, 2026
Intellia Therapeutics: Hereditary Angioedema BLA Completion and ATTR Study Updates
Goldman Sachs · May 11, 2026
Market Focus Shift from Buybacks to Capex
The Market Ear · May 11, 2026
Samsung Biologics NDR Takeaway
Goldman Sachs · May 11, 2026
National Bank of Greece Updating Estimates Post Q1
Goldman Sachs · May 11, 2026
Vodacom Mixed FY26 Results Reassuring on South African Growth
Goldman Sachs · May 11, 2026
The Options Market Has Flipped
Goldman Sachs & Co. LLC · May 11, 2026
The Weekly Brief
J.P. Morgan · May 11, 2026